Page last updated: 2024-10-21

edelfosine and ER-Negative PR-Negative HER2-Negative Breast Cancer

edelfosine has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 2 studies

edelfosine: RN given refers to parent cpd
edelfosine : A racemate comprising equimolar amounts of (R)- and (S)-edelfosine.
1-octadecyl-2-methylglycero-3-phosphocholine : A glycerophosphocholine that is glycero-3-phosphocholine substituted at positions 1 and 2 by octadecyl and methyl groups respectively.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Saraiva, SM1
Gutiérrez-Lovera, C1
Martínez-Val, J1
Lores, S1
Bouzo, BL1
Díez-Villares, S1
Alijas, S1
Pensado-López, A1
Vázquez-Ríos, AJ1
Sánchez, L1
de la Fuente, M1
Ren, D1
Zhu, X1
Kong, R1
Zhao, Z1
Sheng, J1
Wang, J1
Xu, X1
Liu, J1
Cui, K1
Zhang, XH1
Zhao, H1
Wong, STC1

Other Studies

2 other studies available for edelfosine and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
Edelfosine nanoemulsions inhibit tumor growth of triple negative breast cancer in zebrafish xenograft model.
    Scientific reports, 2021, 05-10, Volume: 11, Issue:1

    Topics: Administration, Cutaneous; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Prolife

2021
Targeting Brain-Adaptive Cancer Stem Cells Prohibits Brain Metastatic Colonization of Triple-Negative Breast Cancer.
    Cancer research, 2018, 04-15, Volume: 78, Issue:8

    Topics: Adaptation, Physiological; Animals; Brain Neoplasms; Cadherins; Calcium; Calcium-Calmodulin-Dependen

2018